FFL
TEVA icon

Financial Freedom LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Freedom LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-220
Closed -$6.63K – 356
2026
Q1 		$6.63K Hold
220
– – ﹤0.01% 346
2025
Q4 		$6.87K Hold
220
– – ﹤0.01% 286
2025
Q3 		$4.44K Hold
220
– – ﹤0.01% 315
2025
Q2 		$3.69K Hold
220
– – ﹤0.01% 317
2025
Q1 		$3.38K Hold
220
– – ﹤0.01% 327
2024
Q4 		$4.85K Hold
220
– – ﹤0.01% 315
2024
Q3 		$3.96K Hold
220
– – ﹤0.01% 317
2024
Q2 		$3.58K Hold
220
– – ﹤0.01% 327
2024
Q1 		$3.1K Hold
220
– – ﹤0.01% 324
2023
Q4 		$2.3K Hold
220
– – ﹤0.01% 328
2023
Q3 		$2.24K Hold
220
– – ﹤0.01% 338
2023
Q2 		$1.66K Hold
220
– – ﹤0.01% 363
2023
Q1 		$1.95K Hold
220
– – ﹤0.01% 357
2022
Q4 		$2.01K Buy
+220
New +$1.92K ﹤0.01% 354

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Financial Freedom LLC's TEVA Position: Q2 2026 in Review

Financial Freedom LLC sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 220 shares — an estimated $6.63K sold.

Financial Freedom LLC first reported a position in TEVA in Q4 2022 and held it in 14 quarters. The position peaked at $6.87K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Financial Freedom LLC reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 220 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.63K.
  • Financial Freedom LLC first reported a position in Teva Pharmaceuticals in Q4 2022 and held it in 14 quarters.
  • Financial Freedom LLC's Teva Pharmaceuticals position peaked at $6.87K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.